Bispecific antibodies

Details Bispecific antibodies Bispecific antibodies

2007-06-26

2007-06-26

Chan, Christina (Department: 1644)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

Blood proteins or globulins, e.g., proteoglycans, platelet...

C530S388220, C436S548000

Reexamination Certificate

active

10743697

ABSTRACT:
The present invention discloses bispecific antibodies comprising two antibody variable domains on a single polypeptide chain, wherein a first portion of the bispecific antibody is capable of recruiting the activity of a human immune effector cell by specifically binding to an effector antigen on the human immune effector cell, the first portion consisting of one antibody variable domain, and a second portion of the bispecific antibody specifically binding to a target antigen other than the effector antigen, the target antigen on a target cell other than the human immune effector cell, the second portion comprising one antibody variable domain.

REFERENCES:
patent: 5258498 (1993-11-01), Huston et al.
patent: 5489288 (1996-02-01), Buelna
patent: 5525491 (1996-06-01), Huston et al.
patent: 5658570 (1997-08-01), Newman et al.
patent: 5858682 (1999-01-01), Gruenwald et al.
patent: 623 679 (1994-11-01), None
patent: 573 551 (2003-05-01), None
patent: WO 98/46645 (1998-10-01), None
patent: WO 2004/106383 (1999-04-01), None
patent: WO 01/40312 (2001-01-01), None
patent: WO 01/90190 (2001-11-01), None
patent: WO 03/035694 (2003-05-01), None
patent: WO 99/54440 (2004-12-01), None
Frenken et al, J Biotechnology 78: 11-21, 2000.
Muyldermans et al, J Molecular Recognition 12: 131-140, 1999.
Rudikoff et al, Proc Natl ' Acad Sci USA 79: 179, 1983.
Kobrin et al, J Immunology 146: 2017-2020, 1991.
Barrios et al, J Molecular Recognition 17: 332-338, 2004.
Baynex, “Recombinant protein expression inEscherichia coli,” Curr. Opin. Biotech., 10:411-421, 1999.
Bohlen et al., “Cytolysis of Leukemic B-cells by T-cells activated via two bispecific antibodies,”Cancer Res., 53:4310-4314, 1993.
Brühl, “Deplection of CCR5-expressing cells with bispecific antibodies and chemokine toxins: a new strategy in the treatment of chronic inflammatory diseases and HIV,”J. Immunol., 166:2420-2406, 2001.
Cortez-Retamozo et al., “Efficient tumor targeting by single-domain antibody fragments of camels,”Int. J. Cancer, 98:456-462, 2002.
Davies and Reichmann, “Antibody VH domains as small recognition units,”Biotechnology, 13:475-479, 1995.
Davies and Riechmann, “Single antibody domains as small recognition units: design and in vitro antigen selection of camelized, human VH domains with improved protein stability,”Protein Engineering, 9(6):531-537, 1996.
De Jonge et al., “In vivo retargeting of T cell effector function by recombinant bispecific single chain Fv (anti-CD3×anti-idiotype) induces long-term survival in the murine BCL1 lymphoma model,”J. Immunol., 161:1454-1461, 1998.
Desmyter et al., “Antigen specificity and high affinity binding provided by one single loop of a camel singe-domain antibody,”J. Biol. Chem., 267(28):26285-26290, 2001.
Destmyter et al., “Three camelid VHH domains in complex with porcine pancreatic α-amylase,”J. Biol. Chem., 277(26):23645-23650, 2002.
Dumoulin et al., “Single-domain antibody fragments with high conformational stability,”Protein Science, 11:500-515, 2002.
Conrath et al., “Camel single-domain antibodies as modular building units in bispecific and bivalent antibody constructs,”J. Biol. Chem., 276(10):7346-7350, 2001.
Ewert et al., “Biophysical properties of camelid VHH domains compared to those of human VH3 domains,”Biochemistry, 41:3628-3636, 2002.
Harmsen et al., “Llama heavy-chain V regions consist of at least four distinct subfamilies revealing novel sequence features,”Molecular Immunology, 37:579-590, 2000.
Jobling et al., “Immunomodulation of enzyme function in plants by single-domain antibody fragments,”Nature Biotech., 21:77-80, 2003.
Kufer et al., “Construction and biological activity of a recombinant bispecific single-chain antibody designed for therapy of minimal residual colorectal cancer,”Cancer Immunol. Immunother., 45:193-197, 1997.
Löffer et al., “A recombinant bispecific single-chain antibody, CD19×CD3, induces rapid and high lymphoma-directed cytotoxicity by unstimulated T lymphocytes,”Blood, 95(6):2098-2103, 2000.
Mack et al., “Biologic properties of a bispecific single-chain antibody directed against 17-1A (EpCAM) and CD3,”J. Immunol., 158:3965-3970, 1997.
Mack et al., “A small bispecific antibody construct expressed as a functional single-chain molecule with high tumor cell cytotoxicity,”Proc. Natl. Acad. Sci., USA, 92:7021-7025, 1995.
Muruganandam et al., “Selection of phage-displayed llama single-domain antibodies that transmigrate across human blood-brain barrier endothelium,”FASEB Journal, 16:240-242, 2002.
Muyldermans et al., “Recognition of antigens by single-domain antibody fragments: the superfluous luxury of paired domains,”Trends in Biochemical Sciences, 26(4):230-235, 2001.
Riechmann, “Rearrangement of the former VL interface in the solution structure of a camelised, single antibody VH domain,”J. Mol. Biol., 259:957-969, 1996.
Spinelli et al., “Camelid heavy-chain variable domains provide efficient combining sites to haptens,”Biochemistry, 39:1217-1222, 2000.
Tanha et al., “Optimal design features of camelized human single-domain antibody libraries,”J. Biol. Chem., 276(27):24774-24780, 2001.
Borrebaeck et al., “Kinetic analysis of recombinant antibody-antigen interactions: relation between structural domains and antigen binding,”Biotechnology(N Y), 10(6):697-8, 1992.
Ewert et al., “Biophysical properties of human antibody variable domains,”J Mol Biol, 325:531-53, 2003.

Affiliated with

Also associated with

Rating

Bispecific antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bispecific antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bispecific antibodies will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3888096